|
Ranbaxy stamps out legal move to expand recall
FiercePharma Manufacturing Step by step, Ranbaxy Laboratories is overcoming hurdles as it tries to regain its vaporized market share for generic Lipitor. It got past a recall, figured out how glass particles got into its API and is again manufacturing the drug for the U.S … |
More: continued here
